Skip to main content

Table 2 Characteristics of patients undergoing laparoscopic liver resection

From: Efficacy of laparoscopic liver resection in colorectal liver metastases and the influence of preoperative chemotherapy

History of laparotomy by midline incision

32/43

(76.1%)

 Colostomy

4/32

(12.5%)

 More than two laparotomies

3/32

(9.4%)

Preoperative chemotherapy (n = 14)

  

 mFOLFOX6 + bevacizumab

8

 

 mFOLFOX6

4

 

 FOLFOX4 + bevacizumab

1

 

 FOLFIRI + bevacizumab

1

 

 Median cycle number (course)

7.2 ± 2.4

 

Indications for preoperative chemotherapy

  

 Received chemotherapy in other institution

7

 

 Presence of extrahepatic metastasis

3

 

 Large and multiple tumors

2

 

 Emergency surgery for primary tumor

2

 

Surgical procedures

  

 Pure laparoscopic liver resection

26

(60.5%)

 HALS

9

(20.9%)

 Laparoscopy-assisted liver resection

8

(18.6%)

Recurrence in the remnant liver

16/43

(37.2%)

Repeat hepatectomy

6/16

(37.5%)

Repeat hepatectomy underwent LLH

3/6

(50.0%)

  1. HALS, hand assist laparoscopic surgery;
  2. LLH, laparoscopic liver resection; mFOLFOX6, modified FOLFOX6.